DHR · News · 20260724N
Revenue Performance and Mix
DANAHER CORP /DE/ · 2026-07-24 · Importance 55 · Surprise 32
Danaher exceeded analysts’ revenue expectations in the second quarter of 2026. The bioprocessing business underperformed, although Danaher projected high-single-digit growth for that segment. Diagnostics generated CHF 7.88 billion of the company’s reported CHF 19.48 billion in last-fiscal-year revenue, while the United States contributed CHF 7.91 billion.